神经退行性疾病中的化基因
Hashemi Vida1, Mehranfar Sahar2,3,4, Amin Nikdouz5
1Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran.
Immunology and cell biology
|December 26, 2024
概括
化基因及其受体通过促进免疫细胞进入大脑来驱动神经炎症和神经退行. 针对这些途径为阿尔茨海默氏症和帕金森症等疾病提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 神经退行性和神经炎症性疾病源于蛋白质沉积物 (例如,α-synuclein,β-amyloid,prion).
- 这些沉积物引发炎症反应,包括免疫细胞透到中枢神经系统 (CNS).
- 化基因及其受体在调解这种炎症过程中起着至关重要的作用.
研究的目的:
- 审查化学因子和化学因子受体在神经退行和神经炎症中的作用.
- 探索它们与多发性硬化症,帕金森病和阿尔茨海默病等疾病的相关性.
- 讨论针对化基因通路的潜在治疗策略.
主要方法:
- 关于化学因子,神经炎症和神经退行性疾病的科学文章的文献评论.
- 分析特定化学因子及其受体在疾病发病过程中的作用.
- 检查当前和潜在的治疗干预措施.
主要成果:
- 在中枢神经系统,脑脊液和神经退行性疾病患者的血液中观察到化学激素的失调.
- 透的免疫细胞和驻留的中枢神经系统细胞 (神经元,星球细胞) 都通过化学激素的产生促进神经炎症.
- 化基因是白细胞透和随后的炎症介质释放的组成部分.
结论:
- 化基因及其受体是神经退行性和神经炎症性疾病的病原体的关键参与者.
- 了解这些作用为开发有针对性的治疗提供了基础.
- 向化基因通路代表了治疗衰弱神经系统疾病的有希望的治疗途径.
相关概念视频
01:29Excitatory and Inhibitory Effects of Neurotransmitters
9.8K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.8K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
01:23Role of Neurotransmitters in Memory
428
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
428
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95